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Section A. Materials / General Methods / Instrumentation 
All reagents were purchased from commercial suppliers and used without further purification 
unless stated otherwise. Solvents were deoxygenated by passing Ar through the solvent for 30 
min. 1,5-Dinaphtho[38]crown-10 (DN38C10) was synthesized as previously reported.
1 
Analytical high-performance liquid chromatography (HPLC) was performed on reverse-phase 
HPLC (RP-HPLC) instruments, using a C18-column and a binary solvent system (MeCN and 
H2O with 0.1% CF3CO2H). Thin-layer chromatography (TLC) was performed on silica gel 60 
F254 (E Merck). Column chromatography was carried out on silica gel 60F (Merck 9385, 0.040–
0.063 mm). UV/Vis Absorbance spectra were recorded using a UV-3600 Shimadzu 
spectrophotometer. Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 
Avance III 600 MHz, Bruker Avance III 500 MHz, and Agilent 500 MHz spectrometers, with 
working frequencies of 600, 500, and 500 MHz, respectively (
1
H NMR), and 150, 125, and 125 
MHz, respectively (
13
C NMR). Chemical shifts are reported in ppm relative to the signals 
corresponding to the residual non-deuterated solvents (CD3CN: δH = 1.94 ppm and δC = 1.32 and 
118.26 ppm; CDCl3: δH = 7.26 ppm and δC = 77.16 ppm). High-resolution mass spectra (HRMS) 
were measured on an Agilent 6210 Time-of-Flight (TOF) LC-MS, using an ESI source, coupled 
with Agilent 1100 HPLC stack, using direct infusion (0.6 mL min
–1
). Cyclic voltammetry (CV) 
experiments were carried out at room temperature in argon-purged solutions in DMF with a 
Gamry Multipurpose instrument (Reference 600) interfaced to a PC. All CV experiments were 
performed using a glassy carbon working electrode (0.071 cm
2
). The electrode surface was 
polished routinely with 0.05 μm alumina–water slurry on a felt surface immediately before use. 
The counter electrode was a Pt coil and the reference electrode was a Ag/AgCl electrode. The 
concentration of the sample and supporting electrolyte, tetrabutylammonium hexafluoro-
phosphate (TBAPF6), were 1.0 mM and 0.10 M, respectively. The CV cell was dried in an oven 
immediately before use and argon was flushed continually through the cell as it was cooled down 
to room temperature to avoid condensation of water.  
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B. Synthetic Protocols 
1) 1,4-Bis(3-methoxyphenyl)-1H-1,2,3-triazole – "BMPT" 
 
BMPT: A mixture of 3-ethynylanisole (0.38 g, 2.9 mmol), 3-azidoanisole (0.43 g, 2.9 mmol), 
CuI (55 mg, 0.29 mmol), N,N,N',N',N''-pentamethyldiethylenetriamine (PMDTA, 50 mg, 0.29 
mmol), and deoxygenated THF (30 mL) was stirred at room temperature under Ar for 24 h. The 
crude reaction mixture was concentrated in vacuo and subjected to column chromatography 
using silica gel and CH2Cl2, yielding pure product (0.74 g, 91%) as a pale yellow oil. HRMS-ESI 
for BMPT; Calcd for C16H15N3O2: m/z = 282.1237 [M + H]
+
; Found: 282.1242 [M + H]
+
. 
1
H 
NMR (500 MHz, CDCl3, ppm): δH 8.17 (s, 1H), 7.53 (dd, J = 2.7, 1.5, 1H), 7.46–7.42 (m, 2H), 
7.40 (dd, J = 2.3, 2.3 Hz, 1H), 7.37 (dd, J = 7.9, 7.9 Hz, 1H), 7.32 (ddd, J = 7.6, 1.9, 0.7 Hz, 1H), 
6.99 (ddd, J = 8.0, 2.4, 0.7 Hz, 1H), 6.94–6.91 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 3.91 (s, 3H), 3.90 
(s, 3H).
 13
C NMR (125 MHz, CDCl3, ppm): δC 160.6, 160.1, 148.2, 138.1, 131.5, 130.6, 130.0, 
118.2, 117.9, 114.7, 114.5, 112.4, 110.9, 106.4, 55.7, 55.4. 
 
2) 4,4′-(4,4′-Biphenylene)bipyridine – "Extended Bipyridine = Ex2BIPY" 
 
 
Scheme S2. Synthesis of 4,4′-(4,4′-biphenylene)bipyridine – Ex2BIPY. 
 
Scheme S1. Synthesis of 1,4-bis(3-methoxyphenyl)-1H-1,2,3-triazole – BMPT. 
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Ex
2
BIPY: A mixture of pyridin-4-ylboronic acid pinacol ester (10.0 g, 48.8 mmol), 4,4′-
dibromo-1,1′-biphenyl (6.09 g, 19.5 mmol), Pd(PPh3)4 (1.13 g, 0.970 mmol), Cs2CO3 (22.6 g, 
117 mmol), and a 1:1 mixture of dry PhMe/DMF (500 mL) was heated to 130 ºC under Ar for 
72 h before the hot reaction mixture was rendered acidic (pH 2–3) by adding dropwise 
concentrated HCl, which caused the crude product to precipitate from solution. Then, the 
reaction mixture was cooled to room temperature, filtered, and washed with CH2Cl2. The solid 
was dispersed in H2O at 80 ºC and the insoluble material was filtered off before an aqueous 
NaOH solution (10 M) was added dropwise to the filtrate until the pH was ~8–9, resulting in 
precipitation of the desired product. The solid was filtered and washed with H2O, dissolved in a 
1:1 mixture of hot CHCl3/PhMe, and filtered through Celite. The filtrate was concentrated in 
vacuo, yielding pure Ex
2
BIPY (4.2 g, 71%) as a white solid. HRMS-ESI for Ex
2
BIPY; Calcd 
for C22H16N2: m/z = 309.1386 [M + H]
+
; Found: 309.1383 [M + H]
+
. 
1
H NMR (500 MHz, CDCl3, 
ppm): δH 8.70 (AA' of AA'XX', J = 6.1, 1.6 Hz, 4H), 7.83–7.78 (AA'BB', 8H), 7.57 (XX' of 
AA'XX', J = 6.2, 1.6 Hz, 4H).
 13
C NMR (125 MHz, CDCl3, ppm): δC 150.5, 147.8, 141.1, 137.6, 
127.9, 127.7, 121.6. 
3) Bis(4-bromomethylbenzyl)(4,4′-(4,4′-biphenylene)bipyridin-1-ium)bis(hexafluoro-
phosphate) = "DB•2PF6" 
 
 
Scheme S2. Synthesis of DB•2PF6. 
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DB•2PF6: α,α'-Dibromo-p-xylene (5.14 g, 19.5 mmol) was added to a 1:1 mixture of 
CH2Cl2/MeCN (240 mL) in a round-bottomed three-necked flask and the resulting mixture was 
heated at 50 ºC while stirring until all of the solid material dissolved. Next, the temperature of 
the oil bath was raised to 90 ºC and a suspension of Ex
2
BIPY (600 mg, 1.95 mmol) in MeCN 
(120 mL) was added in four aliquots slowly over the course of 4 h. After heating under reflux for 
24 h, the reaction mixture was cooled to room temperature and the yellow precipitate was 
collected by filtration and washed with CH2Cl2. The yellow solid was dissolved in cold (≤RT) 
MeOH (~1 L) followed by the addition of NH4PF6 (~400 mg) and cold (≤RT) H2O (~1 L), 
resulting in the precipitation of pure DB•2PF6 (1.35 g, 72%) that was collected by filtration as a 
yellowish solid. HRMS-ESI for DB•2PF6; Calcd for C38H31Br2F12N2P2: m/z = 821.0552 [M – 
PF6]
+
; Found: 821.0551 [M – PF6]
+
. 1H NMR (500 MHz, CD3CN, ppm): δH 8.76 (AA' of 
AA'XX', J = 6.3 Hz, 4H), 8.33 (XX' of AA'XX', J = 6.3 Hz, 4H), 8.07 (AA' of AA'BB', J = 8.2 
Hz, 4H), 8.01 (BB' of AA'BB', J = 8.1 Hz, 4H), 7.55 (AA' of AA'BB', J = 7.9 Hz, 4H), 7.46 (BB' 
of AA'BB', J = 7.8 Hz, 4H), 5.70 (s, 4H), 4.61 (s, 4H). 
13
C NMR (125 MHz, CD3CN, ppm): δC 
156.9, 145.3, 143.8, 141.1, 134.5, 134.3, 131.1, 130.3, 129.9, 129.3, 126.2, 64.1, 33.5. 
4) Cyclobis(4,4′-(4,4′-biphenylene)bipyridin-1-ium-1,4-phenylenebis(methylene))tetrakis-
(hexafluorophosphate) – "Extended Viologen Box = Ex2Box•4PF6" 
 
 
Scheme S3. Synthesis of Ex2Box•4PF6 by using various templates. 
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Ex
2Box•4PF6: A representative procedure is described in detailed here. A solution of DB•2PF6 
(600 mg, 0.621 mmol), Ex
2
BIPY (192 mg, 0.621 mmol), and the template pyrene (754 mg, 3.73 
mmol) in dry MeCN (450 mL) was stirred at room temperature for 17 d. The reaction was 
quenched by adding concentrated HCl (2–3 mL), causing the crude product to precipitate from 
solution. The yellowish precipitate was collected by filtration and dissolved in hot MeOH. The 
crude Ex
2
Box•4PF6 was precipitated from the MeOH solution by adding NH4PF6 (~0.5 g) and an 
excess of H2O, and was collected, before being subjected to column chromatography using silica 
gel and CH2Cl2/MeCN (1:1) and 0.25–0.5% NH4PF6 in MeCN (w/v) as the eluents. 
Recrystallization in MeCN on slow vapor diffusion of iPr2O yielded pure Ex
2Box•4PF6 (87–104 
mg, 10–12%) as a pale yellow solid. HRMS-ESI for Ex2Box•4PF6; Calcd for C60H48F24N4P4: m/z 
= 1259.2799 [M – PF6]
+
, 557.1576 [M – 2PF6]
2+
; Found: 1259.2792 [M – PF6]
+
, 557.1590 [M – 
2PF6]
2+
. 1H NMR (500 MHz, CD3CN, ppm): δH 8.74 (AA' of AA'XX', J = 7.0 Hz, 8H), 8.18 
(XX' of AA'XX', J = 6.9 Hz, 8H), 7.89 (AA' of AA'BB', J = 8.6 Hz, 8H), 7.84 (BB' of AA'BB', J 
= 8.6 Hz, 8H), 7.63 (s, 8H), 5.67 (s, 8H). 
13
C NMR (125 MHz, CD3CN, ppm): δC 156.4, 144.8, 
143.4, 137.0, 133.9, 131.0, 129.6, 129.1, 126.0, 64.5. 
Section C. Computational Protocol 
The geometries were optimized in Poisson–Boltzmann solvation model2 for MeCN (ɛ = 37.5 and 
R0 = 2.18 Å) at the level of M06-2x/6-311G with Jaguar 7.5.
3
 The scans for the guest moving in 
the Ex
2
Box
4+
 were carried out by fixing the relative shift between the center of Ex
2
Box
4+
, which 
was defined as the average of four methylene carbons of Ex
2
Box
4+
, and the center of guest, 
which was defined as the average of C(9) and C(10) of anthracene, 9,10-anthraquinone, and 1,4-
anthraquinone. The binding energy of Ex
2
Box
4+guest complex was corrected by deducting the 
cost to remove four MeCN solvent molecules from the cavity of Ex
2
Box
4+
, that is, 11.1 kcal 
mol
–1
. 
Section D. Crystallographic Characterization 
All crystallographic data are available free of charge from the Cambridge Crystallographic Data 
Centre (CCDC) via www.ccdc.cam.ac.uk/data_request/cif. 
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1) Ex
2Box•4PF6 
a) Method. Ex
2
Box•4PF6 (3.4 mg, 2.4 µmol) was dissolved in MeCN (0.8 mL) and the mixture 
was passed through a 0.45-μm filter equally into three 1-mL tubes. The tubes were placed 
together in one 20-mL vial containing iPr2O (~3 mL) and the vial was capped. Slow vapor 
diffusion of iPr2O into the solution of Ex
2
Box•4PF6 in MeCN (3.0 mM) over the course of one 
week yielded colorless single crystals of Ex
2
Box•4PF6. Data were collected at 100 K on a Bruker 
Kappa APEX2 CCD Diffractometer equipped with a CuKα microsource with Quazar optics. The 
solid-state structure of Ex
2
Box
4+
 is shown in Figure S1. 
 
b) Crystal Parameters. [C60H48N4•(PF6)4]•(MeCN)2. Colorless block (0.18 × 0.70 × 0.04 mm). 
Monoclinic, P21/c, a = 20.278(8), b = 12.043(5), c = 14.511(7) Å, α = 90.000, β = 108.579(3), γ 
= 90.000º, V = 3358.9(3) Å
3
, Z = 2, T = 100.01 K, ρcalc = 1.470 g cm
–3
, μ = 2.042 mm–1. Of a 
total of 5570 reflections that were collected, 5570 were unique. Final R1 = 0.0452 and wR2 = 
0.1093. Refined as a two-component twin. The crystal under investigation was found to be non-
merohedrally twinned. The orientation matrices for the two components were identified using the 
program Cell Now
4
 and the data were processed using both orientation matrices with SAINT. 
 
Figure S1. Different crystallographic views of Ex2Box4+. Counterions and solvent molecules 
are omitted for the sake of clarity. 
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The exact twin matrix identified by the integration program was found to 
be –0.99975 –0.00027 0.00057 / 0.00013 –1.00000 –0.00012 / 0.89137 –0.00018 0.99975. The 
second domain is rotated from the first domain by 180° about the reciprocal lattice c-axis (non-
standard setting). The absorption correction was carried out using TWINABS V2008/4
5
 to create 
an hklf5 file, which was used in all refinements; the structure was solved using direct methods 
with only the non-overlapping reflections of component 1. The twin fraction refined to a value of 
0.4162(15). CCDC Number: 913422. 
2) Ex
2
Box (Anthracene)0.5•4PF6(Anthracene) 
 
a) Method A. Solid anthracene (0.70 mg, 3.9 µmol) was added to a solution of Ex
2
Box•4PF6 (3.3 
mg, 2.3 µmol) in MeCN (0.8 mL) and, after it dissolved, the mixture was passed through a 0.45-
μm filter equally into three 1-mL tubes. The tubes were placed together in one 20-mL vial 
 
Figure S2. Different crystallographic views of Ex2Box4+(anthracene)0.5•(anthracene). Half 
of the Ex2Box4+ cyclophanes are occupied with one anthracene molecule and half of the 
Ex2Box4+cyclophanes are empty. Anthracene molecules are disordered and each molecule 
of anthracene can be positioned in four different ways within Ex2Box4+ cyclophane (bottom-
left). Counterions and solvent molecules are omitted for the sake of clarity. 
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containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O into the 2:1 
solution of anthracene and Ex
2
Box•4PF6 in MeCN over the period of 4 d yielded yellow single 
crystals of Ex
2
Box(anthracene)0.5•4PF6(anthracene). Note the structural formula in the Crystal 
Parameters section below reflects an occupancy of only half of the Ex
2
Box•4PF6 cyclophanes 
with anthracene molecules. Data were collected at 100 K on a Bruker Kappa APEX2 CCD 
Diffractometer equipped with a CuKα microsource with MX optics. The solid-state 
superstructure of Ex
2
Box
4+(anthracene)0.5•(anthracene) obtained with this method is shown in 
Figure S2. 
Method B. A solution of anthracene (2.0 mg, 11 µmol) in CHCl3 (0.3 mL) was added to a 
solution of Ex
2
Box•4PF6 (2.0 mg, 1.4 µmol) in MeCN (0.8 mL) and the mixture was passed 
through a 0.45-μm filter equally into three 1-mL tubes. The tubes were placed together in one 
20-mL vial containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O 
into the 8:1 solution of anthracene and Ex
2
Box•4PF6 in MeCN over the period of 4 d yielded 
yellow single crystals of Ex
2
Box(anthracene)0.5•4PF6(anthracene). Data were collected at  
100 K on a Bruker Kappa APEX2 CCD Diffractometer using a CuKα microsource with MX 
optics. The solid-state superstructure was identical to that observed by Method A. 
b) Crystal Parameters. [C60H48N4(C14H10)0.5•(PF6)4]•(C14H10)•(MeCN)2. Yellow block (0.25 × 
0.10 × 0.05 mm). Triclinic, P1  , a = 10.061(3), b = 11.220(4), c = 21.754(7) Å, α = 77.931(18), β 
= 85.603(18), γ = 65.560(16)º, V = 2186.1(13) Å3, Z = 1, T = 100.03 K, ρcalc = 1.333 g cm
–3
, μ = 
0.184 mm
–1
. Of a total of 59360 reflections that were collected, 12946 were unique (Rint = 
0.0376). Final R1 = 0.0898 and wR2 = 0.2662. Distance restraints were refined for the disordered 
anthracene. A group anistropic displacement parameter was refined for the disordered 
anthracene, which was also restrained (esd 0.01) so that its Uij components approximate to 
isotropic. The enhanced rigid-bond restraint was applied to the disordered fluorine atoms and 
anthracene.
6
 The highest peaks in the difference map were located around the disordered 
anthracene indicating some more possible disorder. CCDC Number: 913425. 
3) Ex
2
Box Pyrene•4PF6(Pyrene) 
a) Method. Solid pyrene (1.5 mg, 7.2 µmol) was added to a solution of Ex
2
Box•4PF6 (3.4 mg, 
2.4 µmol) in MeCN (0.8 mL) and, after it dissolved, the mixture was passed through a 0.45-μm 
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filter equally into three 1-mL tubes. The tubes were placed together in one 20-mL vial containing 
iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O into the 3:1 solution of 
pyrene and Ex
2
Box•4PF6 in MeCN over the period of 7 d yielded yellow single crystals of 
Ex
2
Boxpyrene•4PF6(pyrene). Data were collected at 100 K on a Bruker Kappa APEX2 CCD 
Diffractometer equipped with a CuKα microsource with Quazar optics. The solid-state 
superstructure of Ex
2
Box
4+pyrene•(pyrene) is shown in Figure S3. 
 
b) Crystal Parameters. [C60H48N4C16H10•(PF6)4]•(C16H10)•(MeCN)4. Yellow block (0.22 × 0.13 
× 0.09 mm). Triclinic, P1  , a = 10.280(3), b = 11.369(3), c = 21.540(6) Å, α = 78.670(13), β = 
84.909(13), γ = 64.499(13)º, V = 2227.88(11) Å3, Z = 1, T = 100.03 K, ρcalc = 1.471 g cm
–3
, μ = 
0.190 mm
–1
. Of a total of 61143 reflections that were collected, 12838 were unique. Final R1 = 
 
Figure S3. Different crystallographic views of Ex2Box4+pyrene•(pyrene). Each Ex2Box4+ 
cyclophane is occupied with one molecule of pyrene. Pyrene molecules are disordered and 
each molecule of pyrene can be positioned in two different ways within Ex2Box4+ cyclophane 
(bottom-left). Counterions and solvent molecules are omitted for the sake of clarity. 
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0.0910 and wR2 = 0.2082. Distance restraints were refined for the disordered pyrene molecules. 
The enhanced rigid-bond restraint was applied
6
 globally. CCDC Number: 913426. 
4) Ex
2
Box (Tetraphene)0.5•4PF6(Tetraphene)0.5 
a) Method. Solid tetraphene (1.0 mg, 4.4 µmol) was added to a solution of Ex
2
Box•4PF6 (1.0 
mg, 0.71 µmol) in MeCN (0.8 mL) and, after it dissolved, the mixture was passed through a 
0.45-μm filter equally into three 1-mL tubes. The tubes were placed together in one 20-mL vial 
containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O into the 6.2:1 
solution of tetraphene and Ex
2
Box•4PF6 in MeCN over the course of 2 d yielded colorless single 
crystals of Ex
2
Box(tetraphene)0.5•4PF6(tetraphene)0.5. Data were collected at 100 K on a Bruker 
Kappa APEX2 CCD Diffractometer equipped with a CuKα microsource with Quazar optics. The 
solid-state superstructure of Ex
2
Box
4+(tetraphene)0.5•(tetraphene)0.5 is shown in Figure S4. 
 
 
Figure S4. Different crystallographic views of Ex2Box4+(tetraphene)0.5•(tetraphene)0.5. 
Counterions and solvent molecules are omitted for the sake of clarity. 
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b) Crystal Parameters. [C60H48N4(C18H12)0.5•(PF6)4]•(C18H12)0.5•(MeCN)3. Colorless block 
(0.11 × 0.08 × 0.04 mm). Triclinic, P1  , a = 10.415(7), b = 11.339(9), c = 21.467(14) Å, α = 
79.584(18), β = 85.427(13), γ = 65.790(2)°, V = 2274.0(3) Å3, Z = 1, T = 99.98 K, ρcalc = 1.283 g 
cm
–3
, μ = 1.595 mm–1. Of a total of 14610 reflections that were collected, 7508 were unique. 
Final R1 = 0.1060 and wR2 = 0.3191. Distant restraints were imposed on bonds, rigid-bond 
restraints (esd 0.01) were imposed on the displacement parameters as well as restraints on similar 
amplitudes (esd 0.05) separated by less than 1.7 Å on all disordered atoms. The disordered 
tetraphene molecules were restrained (esd 0.01) so that their Uij components approximate to 
isotropic. CCDC Number: 936766. 
5) Ex
2
Box Chrysene•4PF6(Chrysene) 
 
 
Figure S5. Different crystallographic views of Ex2Box4+chrysene•(chrysene). Counterions 
and solvent molecules are omitted for the sake of clarity. 
S15 
 
a) Method. Solid chrysene (0.7 mg, 3 µmol) was added to a solution of Ex
2
Box•4PF6 (2.0 mg, 
1.4 µmol) in MeCN (0.8 mL) and, after it dissolved, the mixture was passed through a 0.45-μm 
filter equally into three 1-mL tubes. The tubes were placed together in one 20-mL vial containing 
iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O into the 2.1:1 solution of 
chrysene and Ex
2
Box•4PF6 in MeCN over the course of 4 d yielded colorless single crystals of 
Ex
2
Boxchrysene•4PF6(chrysene). Data were collected at 100 K on a Bruker Kappa APEX2 
CCD Diffractometer equipped with a CuKα microsource with Quazar optics. The solid-state 
superstructure of Ex
2
Box
4+chrysene•(chrysene) is shown in Figure S5. 
b) Crystal Parameters. [C60H48N4C18H12•(PF6)4]•(C18H12)•(MeCN)4. Colorless block (0.19 × 
0.10 × 0.01 mm). Triclinic, P1  , a = 10.480(4), b = 11.349(5), c = 21.442(9) Å, α = 80.25(3), β = 
86.77(3), γ = 64.519(2)°, V = 2268.6(17) Å3, Z = 1, T = 100.12 K, ρcalc = 1.483 g cm
–3
, μ = 1.687 
mm
–1
. Of a total of 14871 reflections that were collected, 7507 were unique. Final R1 = 0.0447 
and wR2 = 0.1137. Rigid bond restraints (esd 0.01) were imposed on the displacement parameters 
as well as restraints on similar amplitudes (esd 0.05) separated by less than 1.7 Å on the 
disordered carbon atoms of chrysene. Similar distances (SADI) and a flat command were also 
refined for these carbon atoms. CCDC Number: 936767. 
6) Ex
2
Box Tetracene•4PF6(Tetracene) 
a) Method. A mixture of tetracene (0.30 mg, 1.3 µmol), Ex
2
Box•4PF6 (1.7 mg, 1.2 µmol), MeCN 
(0.8 mL), and PhMe (0.8 mL) was heated at 80 ºC for 30 min before an additional portion of 
MeCN (0.8 mL) was added. The resulting solution was then allowed to cool slowly to room 
temperature and was passed through a 0.45-μm filter equally into six 1-mL tubes. The tubes were 
placed in two 20-mL vials (three in each) containing iPr2O (2 mL) and the vials were capped. 
Slow vapor diffusion of iPr2O into the 1.1:1 solution of tetracene and Ex
2
Box•4PF6 in 
MeCN/PhMe over the period of 1 d yielded orange single crystals of 
Ex
2
Boxtetracene•4PF6(tetracene). Data were collected at 100 K on a Bruker Kappa APEX2 
CCD Diffractometer equipped with a CuKα microsource with Quazar optics. The solid-state 
superstructure of Ex
2
Box
4+tetracene•(tetracene) is shown in Figure S6.  
 b) Crystal Parameters. [C60H48N4(C18H12)•(PF6)4]•(C18H12)•(MeCN)4. Orange block (0.23 × 
0.10 × 0.02 mm). Triclinic, P1  , a = 10.480(3), b = 11.384(3), c = 21.556(6) Å, α = 80.426(2), β 
= 86.407(17), γ = 63.302(16)º, V = 2265.29(11) Å3, Z = 1, T = 99.95 K, ρcalc = 1.448 g cm
–3
, μ = 
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1.689 mm
–1
. Of a total of 14958 reflections that were collected, 7309 were unique. Final R1 = 
0.0546 and wR2 = 0.1575. No special refinement was necessary. CCDC Number: 913427. 
 
7) Ex
2
Box (2,6-Dinitrotoluene)•4PF6 
a) Method. Solid 2,6-dinitrotoluene (4.0 mg, 22 µmol) was added to a solution of Ex
2
Box•4PF6 
(3.3 mg, 2.3 µmol) in MeCN (0.8 mL) and, after it dissolved, the mixture was passed through a 
0.45-μm filter equally into three 1-mL tubes. The tubes were placed together in one 20-mL vial 
containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O into the 10:1 
solution of 2,6-dinitrotoluene and Ex
2
Box•4PF6 in MeCN over the period of 4 d yielded 
colorless single crystals of Ex
2
Box(2,6-dinitrotoluene)•4PF6. Data were collected at 100 K on a 
Bruker Kappa APEX2 CCD Diffractometer equipped with a CuKα microsource with MX optics. 
The solid-state superstructure of Ex
2
Box
4+(2,6-dinitrotoluene) is shown in Figure S7. 
 
Figure S6. Different crystallographic views of Ex2Box4+tetracene•(tetracene). Counterions 
and solvent molecules are omitted for the sake of clarity. 
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b) Crystal Parameters. [C60H48N4C7H6N2O4•(PF6)4]. Colorless block (0.17 × 0.08 × 0.03 mm). 
Orthorhombic, Cmca, a = 14.443(6), b = 38.482(14), c = 12.120(4) Å, α = 90.000, β = 90.000, γ 
= 90.000º, V = 6735.9(4) Å
3
, Z = 4, T = 99.99 K, ρcalc = 1.565 g cm
–3
, μ = 2.125 mm–1. Of a total 
of 13160 reflections that were collected, 2799 were unique. Final R1 = 0.0791 and wR2 = 0.2195. 
2,6-Dinitrotoluene (DNT) is disordered over several symmetry elements and refined without 
special position constraints (PART –1). The atoms of the toluene benzenoid ring were refined 
with a perfect hexagon restraint (AFIX 66), and the CAr–CH3, C–N, and N–O distances were 
refined with appropriate distance restraints as taken from a search of similar compounds in the 
Cambridge Structural Database. A group displacement parameter was used for the anisotropic 
refinement of the disordered DNT molecule. CCDC Number: 913429. 
 
 
Figure S7. Different crystallographic views of Ex2Box4+(2,6-dinitrotoluene). Each Ex2Box4+ 
cyclophane is occupied with one molecule of 2,6-dinitrotoluene. 2,6-Dinitrotoluene molecules 
are disordered and can be positioned in several different ways within Ex2Box4+ cyclophane 
(bottom-left). Counterions are omitted for the sake of clarity. DNT = 2,6-dinitrotoluene. 
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8) Ex
2
Box (1,5-Dinitronaphthalene)•4PF6 
a) Method. Solid 1,5-dinitronaphthalene (6.2 mg, 28 µmol) was added to a solution of 
Ex
2
Box•4PF6 (2.0 mg, 1.4 µmol) in MeCN (0.8 mL) and, after it dissolved, the mixture was 
passed through a 0.45-μm filter equally into three 1-mL tubes. The tubes were placed together in 
one 20-mL vial containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of 
iPr2O into the 20:1 solution of 1,5-dinitronaphthalene and Ex
2
Box•4PF6 in MeCN over the 
course of 7 d yielded yellow single crystals of Ex
2
Box(1,5-dinitronaphthalene)•4PF6. Data 
were collected at 100 K on a Bruker Kappa APEX2 CCD Diffractometer equipped with a CuKα 
microsource with Quazar optics. The solid-state superstructure of Ex
2
Box
4+(1,5-
dinitronaphthalene) is shown in Figure S8. 
 
 
Figure S8. Different crystallographic views of Ex2Box4+(1,5-dinitronaphthalene). 1,5-
Dinitronaphthalene molecules are disordered and can be positioned in several different ways 
within Ex2Box4+ cyclophane (bottom-left). Counterions are omitted for the sake of clarity.  
DNN = 1,5-dinitronaphthalene. 
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b) Crystal Parameters. [C60H48N4C10H6N2O4•(PF6)4]. Yellow block (0.19 × 0.16 × 0.01 mm). 
Orthorhombic, Cmca, a = 14.913(6), b = 38.067(17), c = 12.106(5) Å, α = 90.000, β = 90.000, 
γ = 90.000°, V = 6872.8(5) Å3, Z = 4, T = 100.01 K, ρcalc = 1.569 g cm
–3
, μ = 2.098 mm–1. Of a 
total of 13018 reflections that were collected, 3017 were unique. Final R1 = 0.0422 and wR2 = 
0.0994. Rigid-bond restraints were imposed on the displacement parameters as well as restraints 
on similar amplitudes separated by less than 1.7 Å on the disordered 1,5-dinitronaphthalene 
(DNN). The oxygen atoms were restrained so that their Uij components approximate to isotropic. 
Distance restraints were also imposed on the disordered DNN molecule. CCDC Number: 
936768. 
9) Ex
2
Box (9,10-Anthraquinone)0.5•4PF6 
a) Method. Solid 9,10-anthraquinone (6.3 mg, 30 µmol) was added to a solution of Ex
2
Box•4PF6 
(2.2 mg, 1.6 µmol) in MeCN (0.8 mL) and, after it dissolved, the mixture was passed through a 
0.45-μm filter equally into three 1-mL tubes. The tubes were placed together in one 20-mL vial 
containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O into the 19:1 
solution of 9,10-anthraquinone and Ex
2
Box•4PF6 in MeCN over the course of 7 d yielded yellow 
single crystals of Ex
2
Box(9,10-anthraquinone)0.5•4PF6. Note the structural formula in the 
Crystal Parameters section below reflects an occupancy of only half of the Ex
2
Box•4PF6 
cyclophanes with 9,10-anthraquinone molecules. Data were collected at 100 K on a Bruker 
Kappa APEX2 CCD Diffractometer using a CuKα microsource with Quazar optics. The solid-
state superstructure of Ex
2
Box
4+(9,10-anthraquinone)0.5 is shown in Figure S9. 
b) Crystal Parameters. [C60H48N4(C14H10O2)0.5•(PF6)4]•MeCN. Yellow block (0.05 × 0.05 × 
0.03 mm). Monoclinic, P21/c, a = 20.082(37), b = 12.103(4), c = 14.458(6) Å, α = 90.000, β = 
106.223(3), γ = 90.000º, V = 3374.2(2) Å3, Z = 2, T = 100.01 K, ρcalc = 1.528 g cm
–3
, μ = 2.068 
mm
–1
. Of a total of 4115 reflections that were collected, 4115 were unique. Final R1 = 0.0636 
and wR2 = 0.1751. The crystal under investigation was found to be non-merohedrally twinned. 
The orientation matrices for the two components were identified using the program Cell Now,
4
 
and the data were processed using both orientation matrices with SAINT. The exact twin matrix 
identified by the integration program was found to be –1.00119 –0.00053 –0.00309 / 0.00035  
–1.00000 –0.00004 / 0.77107 0.00010 1.00119. The second domain is rotated from the first 
domain by 179.9° about the reciprocal lattice a-axis (reduced cell). The absorption correction 
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was carried out using TWINABS V2008/4
5
 to create an hklf5 file that was used in all 
refinements; the structure was solved using direct methods with only the non-overlapping 
reflections of component 1. The twin fraction refined to a value of 0.351(2). CCDC Number: 
913430. 
 
10) Ex
2
Box(1,4-Anthraquinone)•4PF6 
a) Method. A solution of 1,4-anthraquinone (5.9 mg, 28 µmol) in CHCl3 (0.2 mL) was added to a 
solution of Ex
2
Box•4PF6 (2.0 mg, 1.4 µmol) in MeCN (0.8 mL) and the mixture was passed 
through a 0.45-μm filter equally into three 1-mL tubes. The tubes were placed together in one 
20-mL vial containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of iPr2O 
into the 20:1 solution of 1,4-anthraquinone and Ex
2
Box•4PF6 in MeCN/CHCl3 over the course of 
7 d yielded yellow single crystals of Ex
2
Box(1,4-anthraquinone)•4PF6. Data were collected at 
 
Figure S9. Different crystallographic views of Ex2Box4+(9,10-anthraquinone)0.5. Half of the 
Ex2Box4+ cyclophanes are occupied with one 9,10-anthraquinone molecule and half of the 
Ex2Box4+ cyclophanes are occupied with one MeCN molecule. Counterions and solvent 
molecules are omitted for the sake of clarity. 9,10-AQ = 9,10-anthraquinone. 
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100 K on a Bruker Kappa APEX2 CCD Diffractometer equipped with a CuKα microsource with 
Quazar optics. The solid-state superstructure of Ex
2
Box
4+(1,4-anthraquinone) is shown in 
Figure S10. 
b) Crystal Parameters. [C60H48N4C14H8O2•(PF6)4]•(CHCl3)2. Yellow block (0.45 × 0.14 × 0.12 
mm). Monoclinic, P21/c, a = 9.790(4), b = 14.131(6), c = 27.617(12) Å, α = 90.000,          β = 
95.911(2), γ = 90.000º, V = 3800.4(3) Å3, Z = 2, T = 100.0 K, ρcalc = 1.618 g cm
–3
, μ = 0.421 
mm
–1
. Of a total of 57735 reflections that were collected, 11430 were unique. Final R1 = 0.0722 
and wR2 = 0.2057. The enhanced rigid-bond restraint was applied
6
 globally. CCDC Number: 
936769.
 
 
Figure S10. Different crystallographic views of Ex2Box4+(1,4-anthraquinone). Counterions 
and solvent molecules are omitted for the sake of clarity. 1,4-AQ = 1,4-anthraquinone. 
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11) Ex
2
Box[1,4-Bis(3-methoxyphenyl)-1H-1,2,3-triazole]•4PF6[1,4-Bis(3-methoxyphenyl)-
1H-1,2,3-triazole] 
a) Method. Solid 1,4-Bis(3-methoxyphenyl)-1H-1,2,3-triazole (BMPT) (2.0 mg, 6.4 µmol) was 
added to a solution of Ex
2
Box•4PF6 (2.0 mg, 1.4 µmol) in MeCN (0.8 mL) and, after it 
dissolved, the mixture was passed through a 0.45-μm filter equally into three 1-mL tubes. The 
tubes were placed together in one 20-mL vial containing iPr2O (~3 mL) and the vial was capped. 
Slow vapor diffusion of iPr2O into the 4.6:1 solution of BMPT and Ex
2
Box•4PF6 in MeCN over 
the course of 6 d yielded yellow single crystals of Ex
2
BoxBMPT•4PF6(BMPT). Data were 
collected at 100 K on a Bruker Kappa APEX2 CCD Diffractometer equipped with a CuKα 
microsource with Quazar optics. The solid-state superstructure of Ex
2
Box
4+BMPT•(BMPT) is 
shown in Figure S11. 
 
 
Figure S11. Different crystallographic views of Ex2Box4+BMPT. The BMPT molecules are 
disordered and can be positioned in several different ways within Ex2Box4+ cyclophane 
(bottom-left). Counterions and solvent molecules are omitted for the sake of clarity. 
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b) Crystal Parameters. [C60H48N4C16H15N3O2•(PF6)4]•(C16H15N3O2)•(MeCN)2.5. Colorless 
block (0.11 × 0.08 × 0.04 mm). Triclinic, P1  , a = 10.4059(3), b = 11.3697(3), c = 21.2021(5) Å, 
α = 81.1853(12), β = 86.2716(13), γ = 64.9951(11)°, V = 2246.50(10) Å3, Z = 1, T = 100.03 K, 
ρcalc = 1.530 g cm
–3
, μ = 0.197 mm–1. Of a total of 90082 reflections that were collected, 13104 
were unique. Final R1 = 0.1051 and wR2 = 0.2775. Similar distance restraints were applied to the 
disordered atoms. The enhanced rigid-bond restraint was applied
6
 globally. CCDC Number: 
936770. 
12) Ex
2
Box (1,2,4-Trichlorobenzene)2•4PF6(Tetracene) 
a) Method. A mixture of tetracene (0.30 mg, 1.3 µmol), Ex
2
Box•4PF6 (1.7 mg, 1.2 µmol), MeCN 
(0.8 mL), and 1,2,4-trichlorobenzene (0.8 mL) was heated at 90 ºC for 30 min before an 
additional portion of MeCN (0.8 mL) was added. The resulting solution was then allowed to cool 
slowly to room temperature and was passed through a 0.45-μm filter equally into six 1-mL tubes. 
The tubes were placed in two 20-mL vials (three in each) containing iPr2O (~1.5 mL) and the 
vials were capped. Slow vapor diffusion of iPr2O into the 1.1:1 solution of tetracene and 
Ex
2
Box•4PF6 in MeCN/1,2,4-trichlorobenzene over the period of 3 d yielded yellow single 
crystals of Ex
2
Box(1,2,4-trichlorobenzene)2•4PF6(tetracene). Data were collected at 100 K on a 
Bruker Kappa APEX2 CCD Diffractometer equipped with a CuKα microsource with Quazar 
optics. The solid-state superstructure of Ex
2
Box
4+(1,2,4-trichlorobenzene)2•(tetracene) is 
shown in Figure S12. 
b) Crystal Parameters. [C60H48N4(C6H3Cl3)2•(PF6)4]•(C18H12)•(MeCN)4. Yellow block (0.21 × 
0.12 × 0.04 mm). Triclinic, P1  , a = 10.779(3), b = 11.107(3), c = 21.133(5) Å, α = 81.978(10), β 
= 88.551(10), γ = 67.138(10)º, V = 2307.3(10) Å3, Z = 1, T = 99.99 K, ρcalc = 1.555 g cm
–3
, μ = 
3.257 mm
–1
. Of a total of 22031 reflections that were collected, 7769 were unique. Final R1 = 
0.0435 and wR2 = 0.1208. No restraints or constraints were used in this refinement. CCDC 
Number: 913423. 
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13) Ex
2
Box (1,5-Dinaphtho[38]crown-10)•4PF6 
a) Method. Solid 1,5-dinaphtho[38]crown-10 (30 mg, 48 µmol) was added to a solution of 
Ex
2
Box•4PF6 (3.4 mg, 2.4 µmol) in MeCN (0.8 mL) and, after it dissolved, the mixture was 
passed through a 0.45-μm filter equally into three 1-mL tubes. The tubes were placed together in 
one 20-mL vial containing iPr2O (~3 mL) and the vial was capped. Slow vapor diffusion of 
iPr2O into the 20:1 solution of 1,5-dinaphtho[38]crown-10 and Ex
2
Box•4PF6 in MeCN over the 
course of 7 d yielded orange single crystals of Ex
2
Box(1,5-dinaphtho[38]crown-10)•4PF6. Data 
were collected at 100 K on a Bruker Kappa APEX2 CCD Diffractometer equipped with a CuKα 
microsource with Quazar optics. The solid-state superstructure of Ex
2
Box
4+(1,5-
dinaphtho[38]crown-10) is shown in Figure S13. 
 
Figure S12. Different crystallographic views of Ex2Box4+(1,2,4-trichlorobenzene)2• 
(tetracene). Counterions and solvent molecules are omitted for the sake of clarity. TCB = 
1,2,4-trichlorobenzene. 
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b) Crystal Parameters. [C60H48N4C36H44O10•(PF6)4]•(MeCN)8. Orange block (0.47 × 0.13 × 
0.08 mm). Triclinic, P1  , a = 10.821(3), b = 13.528(3), c = 21.903(6) Å, α = 88.571(13), β = 
86.429(12), γ = 72.761(11)º, V = 3056.3(14) Å3, Z = 1, T = 99.98 K, ρcalc = 1.286 g cm
–3
, μ = 
1.398 mm
–1
. Of a total of 24907 reflections that were collected, 10092 were unique. Final R1 = 
0.0562 and wR2 = 0.1607. The enhanced rigid-bond restraint was applied
6
 to the disordered 
atoms. Distance restraints were also refined for the disordered atoms. CCDC Number: 913424. 
 
 
Figure S13. Different crystallographic views of Ex2Box4+(1,5-dinaphtho[38]crown-10). 
Counterions and solvent molecules are omitted for the sake of clarity. DN38C10 = 1,5-
dinaphtho[38]crown-10. 
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Section E. Spectroscopic and Spectrometric Characterizations 
1) 
1
H NMR Spectroscopic Analysis  
1
H NMR (298 K, 600 MHz) titrations were performed by adding small volumes of a 
concentrated guest solution in CD3CN or CDCl3 to a solution of Ex
2
Box•4PF6 in CD3CN. 
Tetramethylsilane was used as a reference. The upfield shifts of the 
1
H resonances for β, γ, or δ 
protons were observed and used to determine the association constants (Ka). The Ka values were 
calculated using Dynafit,
7
 a program that employs nonlinear least-squares regression on ligand–
receptor binding data. 
The binding ratio for the complex between Ex
2
Box•4PF6 and anthracene in solution was 
obtained from a Job plot (Figure S14) – using an average of two data sets – which was derived 
from chemical shifts of the δ protons of Ex2Box•4PF6 in mixtures of Ex
2
Box•4PF6 and 
anthracene in CD3CN (containing up to 2.5% of CDCl3 for the purposes of solubility) at 25 °C 
by using
 1
H NMR spectroscopy. The data shows a 1:1 binding between Ex
2
Box•4PF6 and 
anthracene. 
 
 
Figure S14. Job plot for the complex between Ex2Box•4PF6 and anthracene in CD3CN at 
room temperature, showing a 1:1 binding ratio in solution. 
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2) Cyclic Voltammetric Analysis 
Cyclic voltammetry was carried out on a 1.0 mM solution of Ex
2
Box•4PF6 in MeCN using  
0.1 M TBAPF6 as the electrolyte and a Ag/AgCl reference electrode at 298 K. The cyclic 
voltammogram (CV) for Ex
2
Box•4PF6 is displayed at the bottom of Figure S15 (green) and 
demonstrates a single, broad reduction and oxidation wave, which are separated by 280 mV. 
Comparing the CV of Ex
2
Box•4PF6 to the CVs of CBPQT•4PF6 (top) and ExBox•4PF6 
(middle), it becomes evident – as the redox couples merge into one starting from CBPQT•4PF6 
and going to Ex
2
Box•4PF6 – that the electronic coupling (communication) decreases as the 
number of the phenylene rings between the pyridinium rings is increased to one (ExBox•4PF6) 
and two (Ex
2
Box•4PF6). This decreased electronic coupling occurs as a result of the torsional 
twisting between each ring, which disrupts the conjugation between the redox centers. 
 
 
Figure S15. Cyclic voltammetry data for CBPQT•4PF6, ExBox•4PF6, and Ex
2Box•4PF6. 
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3) UV/Vis Spectroscopic Analysis 
The UV/Vis absorption spectra were recorded for Ex
2
Box•4PF6 (Figure S16) and its soluble 1:1 
complexes Ex
2
Box•4PF6guest (Figure S17), where the guests ranged from electron-rich (a) 
anthracene, (b) pyrene, (c) tetraphene, and (d) chrysene to electron-poor (e) 2,6-dinitrotoluene 
(DNT), (f) 1,5-dinitronaphthalene (DNN), (g) 9,10-anthraquinone (9,10-AQ), and (h) 1,4-
anthraquinone (1,4-AQ), to (i) 1,4-bis(3-methoxyphenyl)-1H-1,2,3-triazole (BMPT) and (j) 1,5-
dinaphtho[38]crown-10 (DN38C10) all at 0.5 mM in a 1-cm cell at 298 K. It is important to note 
the red-shifted charge-transfer bands in each of the electron-rich guests as a result of the charge-
transfer interactions of the respective guests with Ex
2
Box•4PF6, while the electron-poor guests 
display no appreciable difference in their absorption spectra between the empty cyclophane and 
the mixture of the host and guest either on account of their different modes of binding or weak 
binding at 0.5 mM. Additionally, the UV/Vis spectrum where tetracene is the guest was not 
recorded because of the limited solubility. 
 
 
Figure S16. UV/Vis Spectra of Ex2Box•4PF6 at 0.5 mM in a 1-cm cell at 298 K. 
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Figure S17a–f. UV/Vis Spectra of the soluble 1:1 complexes of Ex2Box•4PF6 guest, where 
the guests are (a) anthracene, (b) pyrene, (c) tetraphene, (d) chrysene, (e) DNT, and (f) DNN 
all at 0.5 mM in a 1-cm cell at 298 K. 
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Figure S17g–j. UV/Vis Spectra of the soluble 1:1 complexes of Ex2Box•4PF6 guest, where 
the guests are (g) 9,10-AQ, (h) 1,4-AQ, (i) BMPT, and (j) D38C10, all at 0.5 mM in a 1-cm 
cell at 298 K. 
